S. DEGIRMENCIOGLU Et Al. , "A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).," Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, pp.136-142, 2019
DEGIRMENCIOGLU, S. Et Al. 2019. A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).. Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24 , 136-142.
DEGIRMENCIOGLU, S., TANRIVERDI, O., MENEKSE, S., DOGAN, M., HACıOGLU, B., OKTAY, E., ... ERDEM, D.(2019). A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).. Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, 136-142.
DEGIRMENCIOGLU, S Et Al. "A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).," Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, 136-142, 2019
DEGIRMENCIOGLU, S Et Al. "A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).." Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, pp.136-142, 2019
DEGIRMENCIOGLU, S. Et Al. (2019) . "A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).." Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.24, pp.136-142.
@article{article, author={S DEGIRMENCIOGLU Et Al. }, title={A retrospective analysis on first-line bevacizumab, cetuximab, and panitimumab-containing regimens in patients with RAS-wild metastatic colorectal cancer: A Collaborative Study by Turkish Oncology Group (TOG).}, journal={Journal of B.U.ON. : official journal of the Balkan Union of Oncology}, year=2019, pages={136-142} }